JEFFREY J. HELMICK, District Judge.
This matter is before me on the Defendants' motion to dismiss Plaintiff's complaint on forum non conveniens grounds. (Doc. No. 11). Also before me are Plaintiff's opposition (Doc. No. 15), Defendants' reply (Doc. No. 16), Plaintiff's surreply (Doc. No. 19), Plaintiff's November 6, 2017 letter (Doc. No. 20), Plaintiff's notice of motion pending (Doc. No. 21), Defendant's notice of supplemental authority (Doc. No. 22), Plaintiff's notices regarding Defendants' continued pursuit of discovery (Doc. No. 23 and Doc. No. 24), and Defendants' letter dated December 12, 2018 (Doc. No. 25). This Court has jurisdiction pursuant to 28 U.S.C. § 1332.
This case is one of many which comprise this multidistrict litigation involving the DePuy ASR hip device which was transferred to this Court in December 2010 by the Judicial Panel on Multidistrict Litigation:
In re DePuy Orthopaedics, Inc., ASR Hip Implant Products Liability Litigation, Case No. 10-md-2197 (N.D. Ohio) (Doc. No. 1). In addition to this MDL, litigation began in numerous state courts including coordinated state court proceedings in California, New Jersey, and Illinois. My colleague, Judge David A. Katz, was assigned this litigation by the Judicial Panel on Multidistrict Litigation.
In January 2011, Judge Katz held a hearing to address initial matters pertaining to this MDL. (Doc. No. 7). He entertained presentations by 82 of the 95 applications seeing appointment to the plaintiffs' leadership. (Doc. No. 63). After the leadership was established, (Doc. No. 71), and at the first official status hearing, the leadership detailed the efforts aimed at discovery, including development of an explant protocol. (Doc. No. 63). There was discussion by both sides regarding coordination with state courts, specifically California and New Jersey, as was done in Judge Katz's prior MDL. (Doc. No. 63). Judge Katz advised there would be monthly meetings of the leadership to keep the litigation on track.
The leadership and their committees began their work in earnest and met regularly with the Court. By the middle of 2013, over 8,500 cases had been filed in this MDL docket with nearly 12,000 individual plaintiffs.
At a hearing on November 19, 2013, this Court along with state court judges from California, New Jersey, Illinois, and Maryland, announced the parties had reached a private, global settlement agreement. Judge Katz then appointed a Plaintiffs' Oversight Committee to:
(Id. at pp. 2-3.)
In conjunction with the DePuy Master Settlement Agreement, the Court approved the appointment of a Claims Administrator and three Special Masters to provide review of the claims process as well as address disputes related to the settlement. (CMO No. 17, Doc. No. 636).
This settlement and subsequent settlements have resulted in resolution for thousands of claimants who had the ASR device implanted. By the summer of 2016, the total number of cases in the MDL was reduced to approximately 2,500. Sadly, Judge Katz passed away unexpectedly at the end of July 2016, and this docket was transferred to me on September 2, 2016. (Doc. No. 1079).
Having provided a brief background of the MDL, I now turn to the Plaintiff's specific case.
DePuy International Limited designed and manufactured the ASR2122 Hip System, a replacement hip for patients experiencing hip joint diseases. (Declaration of Kristin L. Mayer ("Mayer Decl.") at ¶ 4.) It is incorporated and operated in the United Kingdom. DePuy Orthopaedics, Inc. is the Indiana-based company that distributed the ASR2122 Hip System in the United States. (Id. at ¶ 6.) In Spain, the ASR2122 Hip System was distributed by Johnson & Johnson, S.A., a company incorporated there. (Id. at ¶ 5.) In August 2010, DePuy recalled the ASR2122 Hip System and, as a result, its international affiliates (including DePuy Orthopaedics, Inc. in the United States and DePuy International Limited in Spain) withdrew the ASR System. (Id. at ¶¶ 7-8.)
Plaintiff Gwyneth A. Castañeda has been a resident of Spain for over twenty years. Her complaint alleges DePuy's ASR XL Acetabular Hip System was defectively designed and manufactured, or both. She contends DePuy failed to provide adequate warnings concerning the device, which DePuy recalled along with another ASR device, the ASR Hip Resurfacing System in August 2010. Mrs. Castañeda was implanted with the ASR hip in February 2007 in Spain. Her revision surgeries also occurred in Spain. All of her ASR2122 hip implant-related medical care occurred in Spain and was paid for under the Spanish social security system. (Short Form Compl., Doc. No. 1, ¶¶ 6, 8, 10; Plaintiff Fact Sheet ("PFS") at pp. 3-4, 6-8, 13-14, attached to Mayer Decl. at Tab 2, Part 1).
Under the doctrine of forum non conveniens, a court may dismiss actions brought by a foreign plaintiff whose claims would be more appropriately and justly tried in the plaintiff's home country.
Hefferan v. Ethicon Endo-Surgery Inc., 828 F.3d 488, 492 (6th Cir. 2016) (citing Rustal Trading US, Inc. v. Makki, 17 F. App'x 331, 335 (6th Cir. 2001)).
Where appropriate, the trial court must address the proper degree of deference due to a plaintiff's forum selection. Zions First Nat'l Bank v. Moto Diesel Mexicana, S.A. de C.V., 629 F.3d 520, 525 (6th Cir. 2010). Finally, a "forum non conveniens determination is committed to the sound discretion of the trial court." Piper Aircraft Co. v. Reyno, 454 U.S. 235, 257 (1981).
As the analysis in a forum non conveniens case depends on the particular facts presented in that case, "the Supreme Court has `repeatedly rejected the use of per se rules in applying the doctrine.'" Hefferan, 828 F.3d at 493 (quoting Am. Dredging Co. v. Miller, 510 U.S. 443, 455 (1994) (quotation marks omitted)). The Sixth Circuit has noted that "[a] foreign plaintiff's forum choice is usually accorded less deference because the assumption of convenience is `much less reasonable.'" Id. at 494 (quoting Piper Aircraft, 454 U.S. at 245).
"A person's true home, the centuries-old concept of domicile, requires physical presence and intent to remain: that is, `residence at a particular place accompanied with positive or presumptive proof of an intention to remain there for an unlimited time.'" Id. at 493 (quoting Mitchell v. United States, 88 U.S. 350, 352 (1874)). Mrs. Castañeda resides and is domiciled in Spain. The Plaintiff has not shown that her decision to file suit in the United States was motivated by a legitimate reason such as convenience or the ability to obtain jurisdiction over the defendants rather than tactical advantage. See id. (citing Iragorri v. United Technologies Corp., 274 F.3d 65, 72-73 (2nd Cir. 2001)). Therefore, the presumption of convenience applies with less force to her choice of the United States as a forum. Id.
The "adequate alternative forum requirement is satisfied by showing that a defendant is `amenable to process' in the foreign jurisdiction." Estate of Thomson ex rel. Estate of Rakestraw v. Toyota Motor Corp. Worldwide, 545 F.3d 357, 365 (6th Cir. 2008) (citing Gulf Oil Corp. v. Gilbert, 330 U.S. 501, 506-07 (1947)). In response to the risk that American courts would become overly-attractive to foreign litigants, this Court does not weigh the relative favorability of each forum's law unless "the remedy provided by the alternative forum is so clearly inadequate or unsatisfactory that it is no remedy at all...." See Piper Aircraft, 454 U.S. at 263-65; Hefferan, 828 F.3d at 495 ("Law that is simply less favorable to the plaintiff in the alternative forum is not so extraordinary as to render that forum inadequate.") (citing Wong v. PartyGaming Ltd., 589 F.3d 821, 831 (6th Cir. 2009)).
An alternative forum is adequate if it provides some potential avenue for redress even if it fails to provide the same range of remedies as the original forum. See, e.g., Piper Aircraft, 454 U.S. at 254-55 (finding Scotland adequate even though plaintiffs would be barred from bringing strict liability claims and would be subject to lower damage limits); Wong, 589 F.3d at 831 ("[T]he inability to bring a class suit would not render Gibraltar an inadequate alternative forum."). The Sixth Circuit notes, "[t]he relevant question for purposes of forum non conveniens is whether those differences render the possible remedy so clearly inadequate that forcing a plaintiff to bring suit there would be unjust." Hefferan, 828 F.3d at 495.
In this case, Spain provides ample avenues to resolve Plaintiff's claims. (Declaration of Joaquin Ruiz Echauri ("Echauri Decl.") at ¶ 21.). The Spanish legal system provides multiple causes of action that would enable Plaintiff to obtain relief for injuries asserted in her complaint, including claims based on negligence as well as Spain's product liability law. (See Echauri Decl. at ¶¶ 6, 11, 27-32.); see also Kryvicky v. Scandinavian Airlines System, 807 F.2d 514, 518 (6th Cir. 1986) (affirming lower court finding of Spain as an adequate alternative forum for adjudication of wrongful death claims against airline and aircraft manufacturer arising out of plane crash in Madrid); Barak v. Zeff, 289 F. App'x 907 (6th Cir. 2008) (affirming lower court finding of Spain as an adequate alternative forum for the adjudication of Plaintiff's fraud, misrepresentation, and intentional infliction of emotional distress claims).
In addition, dismissal on forum non conveniens grounds is conditioned upon the defendant's submission to the jurisdiction of the foreign court. See Kryvicky, 807 F.2d at 516. This condition is met in this case because Defendant DePuy International Limited, the proper Defendant for claims arising in Spain, has agreed to accept service of process there. (See Mayer Decl. at ¶ 3); (Echauri Decl. at ¶ 36); see also Stewart v. Dow Chemical Co., 865 F.2d 103, 107 (6th Cir. 1989). Further, the Defendants agree they will waive any "applicable statute of limitations/repose defense that may be available under Spanish law," and that they will "satisfy any final, post-appeal judgment awarded to Plaintiffs." (Supplemental Declaration of Kristen L. Mayer, Doc. No. 16-1 at 2).
In Heffernan, the Sixth Circuit addressed the balance of private and public interest factors:
Hefferan, 828 F.3d at 498 (citing Duha v. Agrium, Inc., 448 F.3d 867, 879 (6th Cir. 2006)).
Although a plaintiff's choice of forum ordinarily receives deference in weighing these interests, that "assumption is much less reasonable" when the plaintiff is foreign because "the central purpose of any forum non conveniens inquiry is to ensure that the trial is convenient, [and] a foreign plaintiff's choice deserves less deference." See Piper Aircraft, 454 U.S. at 266. In addition, the Court is more likely to dismiss in situations where a foreign plaintiff brings a tort action against a U.S.-based company, but all relevant events occurred outside the United States. See e.g., Kryvicky, 807 F.2d at 518 (affirming dismissal of claims arising out of plane crash in Spain).
The relevant private interest factors to be considered include:
Gulf Oil, 330 U.S. at 508.
Mrs. Castañeda has never been a resident of the United States nor has she received medical care here. (Doc. No. 11-1 at 3). It is undisputed she has lived in Spain for over twenty years, and all hip implant-related medical treatment, including her implant and revision surgeries, occurred in that country. (Doc. 1, ¶¶ 3, 6, 8, 10; PFS at pp. 3-6, 13-14, 22-25.) Thus, all evidence related to causation and damages is located in Spain, including key physician witnesses and documents. Moreover, Mrs. Castañeda's medical history will likely play a large role in the adjudication of her claim, but her medical records and treating physicians — including those who implanted the device and those who removed it — are located in Spain. Last, no component of Plaintiff's ASR2122 Hip System was designed, manufactured, assembled, or packaged in the United States. (Mayer Decl. at ¶¶ 4-6.)
A trial in the United States will unfairly prejudice the Defendants by imposing barriers on their ability to secure crucial medical evidence, and prevent them from presenting this evidence through the live testimony of the medical professionals involved in Plaintiff's care and treatment. Unlike Spanish courts, the United States lacks subpoena power to compel the production of Spanish witnesses for trial in this country. (Echauri Decl. at ¶ 36).
Defendants face a significant procedural hindrance if they cannot compel the attendance of critical third-party witnesses at trial, such as Plaintiff's treating physicians (including the physicians who surgically implanted and explanted the device at issue). See Lee Yu- Ge v. Johnson & Johnson, 2011 WL 3566859, at *3 (N.D. Ohio, Aug. 12, 2011) (dismissing case where plaintiff, her physician, and her medical records were all located outside the United States, and noting, "there is no ability to compel witnesses who reside in Taiwan to appear in [sic] United States") (citation omitted)); see also Gulf Oil, 330 U.S. at 511 ("Certainly to fix the place of trial at a point where litigants cannot compel personal attendance and may be forced to try their cases on deposition, is to create a condition not satisfactory to court, jury, or most litigants.").
Most of the evidence relating to Plaintiff's claims is in Spain, including documents and witnesses. The inability of this Court to compel the production of witnesses from Spain, and the forced reliance on deposition testimony and medical records which must be translated to English are facts which weigh in favor of the Defendants in this forum non conveniens analysis.
The analysis also requires consideration of the following public interest factors:
Gulf Oil, 330 U.S. at 508-09.
Spain has a significant interest in Plaintiff's claims because the alleged injury occurred in Spain and the allegedly injured party is a Spanish resident. Piper Aircraft, 454 U.S. at 260 ("[T]here is a local interest in having localized controversies decided at home.") (quoting Gulf Oil, 330 U.S. at 509 (internal quotations omitted)). Spain also has an interest in Plaintiff's product liability claims because they squarely implicate the regulatory and policy judgments of Plaintiff's home government.
Comity concerns also suggests deference to Spain which makes its own decisions about what products it wants available to its citizens, including the regulatory and safety scheme it has devised for doing so. See Piper Aircraft, 454 U.S. at 260-61. These decisions would be undermined if a United States court and jury were entitled to hear and decide claims brought by Mrs. Castañeda, who was a resident of Spain during the events at issue. As this Court explained in Bloch:
Bloch v. DePuy Orthopaedics, Inc., 2012 WL 13034558, at *3 (N.D. Ohio, Sept. 12, 2012) (quoting Doe v. Hyland Therapeutics Div., 807 F.Supp. 1117, 1129 (S.D.N.Y. 1992)). The Hyland court also noted it was "ill-equipped to enunciate the optimal standards of safety or care for products sold in distant markets, and thus choose[s] to refrain from imposing [its] determination of what constitutes appropriate behavior to circumstances with which [it] [i]s not familiar." 807 F. Supp. at 1129-30.
Additionally, trying Plaintiff's case in the United States would create the problem of "conducting complex exercises in comparative law." Piper Aircraft, 454 U.S. at 251. Under the governing choice-of-law rules, Spanish law would likely apply, and this Court would have to engage in the cumbersome task of analyzing Spanish law and applying it to multiple principles of U.S. law, including negligence, products liability, and fraud. The United States Supreme Court has held that the burden of applying foreign law in such circumstances "point[s] towards dismissal." Piper Aircraft, 454 U.S. at 260.
In balancing all of the private and public interest factors in this case, I conclude they weigh in favor of dismissal on forum non conveniens grounds. Mrs. Castañeda's claims have a seemingly tenuous connection to this country and she has ample opportunity to pursue her claims in Spain because DePuy International Limited has submitted to jurisdiction there. Additionally, Spain has a highly localized interest in adjudicating this controversy, while the United States has very little at stake. Finally, the Court would overburden local juries to decide a case concerning the injuries suffered by a foreign plaintiff in a foreign land. See Gulf Oil, 330 U.S. at 508-09 (finding the United States judicial system also has an important interest in avoiding both the congestion of the federal courts and the overburdening of taxpayers who would bear the costs for an action that has no connection to their country.).
Mrs. Castañeda contends Defendants waived their forum non conveniens defense because they "knew the facts that form their [forum non conveniens] motion but failed to timely raise the defense." (Doc. No. 15 at 9). But neither this Court nor the Sixth Circuit has considered timeliness in a forum non conveniens analysis, and it need not do so here.
Mrs. Castañeda relies on Rustal Tradings to support her position that "a motion for [forum non conveniens] dismissal must be made within a reasonable time after the defendant has become aware of the facts that form the basis of the motion." (Doc. No. 15 at 5 (citing Rustal Tradings, 17 F. App'x. at 338)). There is nothing on the docket, however, to indicate that any case-specific discovery or movement was made in this case until sometime after December 2014, at which time Mrs. Castañeda filed a Notice of Compliance regarding information relative to the private, national settlement. The Defendants' motion to dismiss was filed less than one year later. Accordingly, in the context of a multidistrict litigation docket, this Court finds a motion to dismiss on forum non conveniens grounds to be reasonably timed when made after case-specific discovery has commenced.
For the reasons stated above, the Defendants' motion to dismiss on forum non conveniens grounds, (Doc. No. 11), is granted.
So Ordered.